BEONE MEDICINES (06160) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile

Industry

Innovative Drugs & Biologics 1.67%

124 stocks in this industry

8 >7%

6 5~7%

16 3~5%

50 0~3%

11 0%

26 0~3%

6 3~5%

0 5~7%

1 >7%

Down 80 Up 33

Industry RankingsValue (HKD)Rank

Revenue (Last FY)291.37B2/112

Net Profit (Last FY)15.83B2/125

ROE (Last FY)6.58%38/117

Change is the 2026-10-13 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

欧雷强 Executive Director

Felix J. Baker Non-Executive Director

王晓东 Non-Executive Director

Olivier Brandicourt Independent Non-Executive Director

Margaret Han Dugan Independent Non-Executive Director

Anthony C. Hooper Independent Non-Executive Director

Elizabeth F. Mooney Independent Non-Executive Director

Alessandro Riva Independent Non-Executive Director

Charles L. Sawyers Independent Non-Executive Director

Shalini Sharp Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-12.

About this page

This page shows BEONE MEDICINES (06160) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

BEONE MEDICINES 06160

Company Information

Industry

Management

BEONE MEDICINES 06160·

Company Information

Industry

Management

BEONE MEDICINES 06160